GlaxoSmithKline Pharmaceuticals500660Meeting schedule update
GSK Pharmaceuticals schedules digital group investors/analysts meet on 4 November 2026
By ScoutQuest · · 1 min read
- Meeting Date
- 4th November 2026
- Meeting Type
- Group meeting with investors/analysts
- Mode
- to be held digitally
- Investors
- unknown
- Organiser
- Group meeting with investors/analysts — organiser not stated
GSK Pharmaceuticals schedules digital group investors/analysts meet on 4 November 2026.
Also from GlaxoSmithKline Pharmaceuticals
GSK India to foray into haemato-oncology with BLENREP launch; adds Calpol 500 and Eltroxin line extensions in Q2 FY2027
3 Nov 2026
Q2 results, new Ethics & Compliance Head and new Statutory Auditors approved by board
3 Nov 2026
Board approves Q2 results, new Ethics & Compliance Head and Walker Chandiok as statutory auditors
3 Nov 2026
Source: BSE · 28 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.